Medical Devices, Diagnostics Equipment & Surgical Platforms
Medical Devices
Executive Search
70+ Medical Device Placements — with an average 73 Days time-to-placement and a 12-month candidate guarantee.
70+
Medical Device Placements
73 Days
Avg. Time-to-Placement
91%
Offer Acceptance Rate
12 Months
Candidate Guarantee
Specialisation withinHealthcare & Life Sciences·Advancing Human Health
Medical devices is the fastest-growing cross-over industry between healthcare and engineering — a sector where product strategy requires clinical empathy, regulatory timelines run in years rather than quarters, and commercial success depends on clinician adoption curves that no pure-software marketing motion can accelerate. India's medical devices industry has evolved from a distribution-led import market into a three-layered ecosystem: global multinationals with deep India commercial operations and increasingly India-based R&D, India-HQ device companies spanning cardiology, orthopaedics, ophthalmology, IVD, anaesthesia, and surgical platforms, and a new generation of venture-backed deep-tech device start-ups built around specific clinical insights.
Is This Your Situation?
If any of these sound familiar, you're speaking to the right practice.
→Global medical-device MNC entering India / expanding its India charter hiring an India MD alongside a parallel Regulatory Affairs leader and Head of Clinical Affairs — a three-role leadership-team build inside six months.
→India-HQ cardiology-device company running founder-succession — confidential CEO search with board chair, investor syndicate, and anchor-clinician advisor participation.
→PE-held orthopaedic-implant platform hiring a VP R&D with device-product craft, design-control fluency, and prior FDA 510(k) / EU MDR approval-shipping experience.
→Venture-backed surgical-robotics start-up hiring a Chief Commercial Officer with deep surgeon-relationship fluency and global-market expansion experience.
Our Medical Devices Track Record
Situation:
A global medical-device MNC entering the Indian market as a direct-presence operation (moving from a distributor-led model) needed an India MD to build the commercial and regulatory team from zero. The brief required prior India device-MNC leadership and the gravitas to represent India to APAC regional HQ.
Outcome:
Placed an India MD with 22 years of device-industry tenure including prior MNC India leadership and subsequent India-HQ device company CEO experience. Engagement included parallel VP Regulatory Affairs and Head of Clinical Affairs placements on the same slate — a three-role leadership team built inside seven months.
Situation:
A PE-held cardiology-device company with approved products in India and emerging export ambitions needed a CEO succession. The incoming CEO had to balance continued India-market commercial compounding, FDA 510(k) export-approval pipeline, and the cultural continuity to retain anchor founding engineering talent.
Outcome:
Placed a CEO with prior device-company leadership in the same clinical segment and subsequent global-device-MNC regional GM experience. Search ran 104 days with confidential founder and PE-sponsor alignment. Incoming CEO delivered FDA 510(k) approval for the flagship product within 14 months of joining.
Situation:
An export-oriented Indian orthopaedic-implant company needed a VP Regulatory Affairs with FDA, EU MDR, and CDSCO concurrent-fluency to lead the regulatory build-out ahead of targeted US and EU market entries. The role reported to the CEO and the board Quality & Regulatory Committee.
Outcome:
Placed a VP Regulatory Affairs who had previously led regulatory at a US device peer and subsequently advised Indian and global device clients on cross-border submissions. Within 12 months the company completed two FDA 510(k) approvals and one EU MDR Class IIb certification.
All client details anonymised. Specific mandates available for reference under NDA upon request.
Our Medical Devices Practice
Medical devices is the fastest-growing cross-over industry between healthcare and engineering — a sector where product strategy requires clinical empathy, regulatory timelines run in years rather than quarters, and commercial success depends on clinician adoption curves that no pure-software marketing motion can accelerate. India's medical devices industry has evolved from a distribution-led import market into a three-layered ecosystem: global multinationals with deep India commercial operations and increasingly India-based R&D, India-HQ device companies spanning cardiology, orthopaedics, ophthalmology, IVD, anaesthesia, and surgical platforms, and a new generation of venture-backed deep-tech device start-ups built around specific clinical insights.
We place leaders across MNC India general managers, MD roles for India-headquartered device companies, VP R&D and Chief Technology Officers, regulatory-affairs leaders, clinical-affairs and medical-affairs heads, commercial leadership across hospital and institutional channels, and independent directors with device-sector gravitas. Engagements include full India leadership team build-outs for MNCs entering the Indian market, founder-succession searches for India-HQ device companies, and cross-border searches that combine Indian commercial depth with US / EU regulatory fluency.
Our practice is distinguished by the understanding that medical devices is a different talent market from pharmaceuticals, healthcare services, or classical engineering. Device-product leaders operate under FDA 510(k), EU MDR, and CDSCO device-classification regimes concurrently; clinical-affairs leaders manage pre-market and post-market evidence strategies; commercial leaders operate through surgeon and hospital-purchase-committee channels that require deep relationship and clinical-evidence fluency. We calibrate mandates to these specific realities.
As a specialist CEO mandates in healthcare, our practice also covers CTO leadership for device companies, our practice also covers Chief Legal Officer mandates, and as a source for Healthcare & Life Sciences practice overview.
The Medical Devices Landscape Today
India's medical devices industry has crossed $12 billion and is projected to reach $50 billion by 2030, with compounded growth driven by hospital-capacity expansion, insurance-empanelment deepening, PLI and Make-in-India incentives for device manufacturing, and growing export ambitions (particularly for IVD, orthopaedic implants, and surgical consumables). India is home to over 50 global medical-device MNC operations, several of which now house regional-headquarter and R&D charters for Asia-Pacific. India-HQ device companies have consolidated across cardiology (stents, pacemakers), orthopaedics (implants, arthroplasty), ophthalmology (IOLs, surgical systems), IVD (immunoassay, clinical chemistry), anaesthesia, critical-care equipment, and surgical energy platforms. The PLI scheme for medical devices has catalysed domestic manufacturing investment with associated leadership-hiring demand for plant heads, quality, and regulatory-compliance leaders. Venture-backed device start-ups have emerged around specific clinical insights — surgical robotics, digital-pathology imaging, wearable cardiac monitoring, ophthalmic diagnostic platforms — creating a new leadership-hiring sub-market that blends clinical, engineering, and regulatory-affairs fluency. The regulatory envelope has tightened — CDSCO's device-classification framework has matured, MDR-2017 compliance is standard, and the MvPI pharmacovigilance-equivalent for devices has become a board-level topic.
Key Leadership Challenges in Medical Devices
India MD / GM searches for medical-device MNCs — leaders with commercial and regulatory fluency, hospital-channel depth, and the gravitas to operate under parent-company governance while representing India to APAC or global HQ.
CEO / MD searches for India-HQ device companies — including founder-succession, pre-IPO leadership, and PE-held platform CEO placements.
VP R&D and CTO searches — engineering-leadership talent with device-product craft, hardware-software integration, and regulatory-design-control fluency.
Regulatory Affairs leadership — VPs and Heads of Regulatory Affairs with FDA 510(k), EU MDR, and CDSCO concurrent-fluency for export-oriented Indian device companies.
Clinical Affairs and Medical Affairs leadership — physician-leaders and clinical-operations heads who manage pre-market clinical evidence, post-market surveillance, and KOL engagement programmes.
Commercial leadership — Head of Hospital / Institutional Sales, Head of Key Accounts, and Head of Government Business for high-touch device-selling motions.
What We Look For in Medical Devices Leaders
Across mandates, medical devices leadership tends to cluster into a small set of archetypes. We calibrate each search against the profile your board actually needs — not the one most commonly available.
The MNC India MD
Leader who has run an India medical-device MNC operation — fluent in hospital-channel commercial, regulatory operating under CDSCO, public-hospital / government-tender commercial, and parent-company governance. Often a career device operator with 20+ years of sector tenure.
The Indian Device CEO
Executive who has run an India-HQ device company P&L — including R&D, regulatory, manufacturing, and commercial concurrently. Fluent in the specific rhythm of device product cycles, clinical-evidence generation, and the commercial dynamics of surgeon / hospital-purchase-committee channels.
The Device VP R&D / CTO
Engineering leader with device-product craft, hardware-software integration depth, and design-control regulatory fluency. Fluent in the standards envelope (ISO 13485, IEC 60601, IEC 62304 for software-in-device) and the R&D-to-regulatory-to-commercial transition rhythm.
The Regulatory Affairs VP
Regulatory-affairs leader with FDA 510(k), EU MDR, and CDSCO concurrent-fluency. Fluent in device-classification strategy, regulatory-submission build, clinical-evaluation reports, and post-market surveillance architecture.
The Clinical Affairs Head
Physician-leader or senior clinical-operations professional with pre-market clinical-evidence strategy, post-market surveillance, and KOL-engagement experience. Often a physician who transitioned into industry after a clinical fellowship or academic tenure.
The Device Chief Commercial Officer
Commercial leader with hospital / institutional channel depth, surgeon-relationship fluency, and clinical-evidence-led selling discipline. Fluent in the operating rhythm of device selling — trial-use pilots, clinical-evidence-led adoption, and purchase-committee cycles.
Regulatory & Compensation Context
Regulatory Backdrop
Medical-device leadership operates under the most regulated envelope of any healthcare sub-sector. The CDSCO under the MDR-2017 governs device classification (Class A/B/C/D), pre-market registration, manufacturing-licence, and import-licence obligations. The DCG(I) issues device-specific import licences and pre-market approvals. BIS certification applies to specific device categories. AERB regulations govern radiation-modality devices. For export-oriented Indian device companies, FDA 510(k) and De Novo classification, EU MDR 2017/745 and IVDR 2017/746, PMDA approvals for Japan, and Health Canada and TGA frameworks form the core export regulatory envelope. ISO 13485 quality-management certification is standard; ISO 14971 risk-management, IEC 60601 for electrical-safety, IEC 62304 for medical-device software, and specific device-category standards (ISO 14630 for surgical implants, ISO 15223 for labelling) are design-control obligations. Post-market surveillance under MvPI (the Indian device pharmacovigilance equivalent) and parallel FDA / EU obligations adds ongoing compliance depth. For listed Indian device companies, SEBI LODR device-industry-specific disclosures, recall governance, and product-liability disclosure discipline are standing board-level topics. DPDP Act applicability to device-generated patient data requires specific data-governance architecture, particularly for connected devices.
Compensation Architecture
Medical-device leadership compensation has re-rated meaningfully, though the market remains more structured than high-velocity SaaS or BFSI peers. India MDs of global device MNCs command ₹5-12 crore fixed cash, 50-100% annual bonus tied to revenue and EBITDA, and parent-company equity (RSUs or PSUs) that typically contributes 30-50% of total comp. CEOs of India-HQ device companies (listed, pre-IPO, or PE-held) price at ₹4-10 crore fixed with equity — listed-company RSUs or pre-IPO grants at 1-3% for hired CEOs. VP R&D / CTO roles command ₹3-7 crore fixed with 0.5-1.5% equity at pre-IPO stages. VP Regulatory Affairs and VP Clinical Affairs at scale-stage device companies price at ₹2-4.5 crore fixed, with a premium for candidates combining FDA / EU MDR plus CDSCO fluency. Chief Commercial Officers command ₹3-6 crore fixed with variable tied to commercial P&L. Plant Heads for PLI-scheme device manufacturing price at ₹2-4.5 crore fixed with completion and stabilisation bonuses. Independent directors on listed device-company boards are compensated at ₹40-70 lakh per year in cash plus committee-chair premiums, with medical / clinical-committee chairs at upper-band. Retention through MNC counter-offers and PLI-beneficiary competing offers is a standing conversation.
Roles We Typically Place
Why Gladwin International Leadership Advisors for Medical Devices
India MD / GM searches for MNC medical-device operations — including full India leadership team build-outs for new-market entrants.
CEO / MD / COO searches for India-HQ device companies (listed, pre-IPO, PE-held).
VP R&D, CTO, and Head of Engineering searches for device product companies.
Regulatory Affairs, Clinical Affairs, and Medical Affairs leadership placements.
Commercial leadership across hospital, institutional, government, and international-export channels.
Independent director and board-chair searches with medical-device sectoral gravitas.
Organisations We Serve
Global medical-device MNCs with India operations
India-HQ device companies across cardiology, orthopaedics, ophthalmology, IVD
Surgical and critical-care equipment manufacturers
Venture-backed device start-ups
PE-held medical-device platforms
Contract manufacturers and PLI-beneficiary device-manufacturing operations
Medical Devices leaders assessed on the Healthcare “VITALIS” framework
Seven dimensions calibrated for healthcare and life sciences leadership. Dimensions are calibrated for medical devices mandates where relevant.
Parent Practice
Return to Healthcare & Life Sciences
Discuss a Medical Devices Mandate
Confidential · No obligation
Response within 4 business hours · All enquiries handled by a senior practice partner · Strictly confidential